nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Dysmetria—Fluorouracil—head and neck cancer	0.12	0.122	CcSEcCtD
Hyoscyamine—Intoxication—Hydroxyurea—head and neck cancer	0.0374	0.038	CcSEcCtD
Hyoscyamine—Poisoning—Hydroxyurea—head and neck cancer	0.0374	0.038	CcSEcCtD
Hyoscyamine—Unsteadiness—Fluorouracil—head and neck cancer	0.0361	0.0367	CcSEcCtD
Hyoscyamine—Cerebellar syndrome—Fluorouracil—head and neck cancer	0.0361	0.0367	CcSEcCtD
Hyoscyamine—Speech impairment NOS—Fluorouracil—head and neck cancer	0.0332	0.0337	CcSEcCtD
Hyoscyamine—Ileus paralytic—Vinblastine—head and neck cancer	0.0255	0.0259	CcSEcCtD
Hyoscyamine—Scab—Fluorouracil—head and neck cancer	0.0228	0.0231	CcSEcCtD
Hyoscyamine—Blepharitis—Hydroxyurea—head and neck cancer	0.0164	0.0166	CcSEcCtD
Hyoscyamine—Slurred speech—Fluorouracil—head and neck cancer	0.0162	0.0165	CcSEcCtD
Hyoscyamine—Granisetron—CYP1A1—head and neck cancer	0.016	1	CrCbGaD
Hyoscyamine—Balance disorder—Fluorouracil—head and neck cancer	0.0132	0.0135	CcSEcCtD
Hyoscyamine—Sinus tachycardia—Docetaxel—head and neck cancer	0.013	0.0132	CcSEcCtD
Hyoscyamine—Blepharitis—Fluorouracil—head and neck cancer	0.0118	0.012	CcSEcCtD
Hyoscyamine—Heartburn—Fluorouracil—head and neck cancer	0.0105	0.0107	CcSEcCtD
Hyoscyamine—Photophobia—Vinblastine—head and neck cancer	0.0104	0.0105	CcSEcCtD
Hyoscyamine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.0096	0.00976	CcSEcCtD
Hyoscyamine—Blood urea increased—Hydroxyurea—head and neck cancer	0.0095	0.00965	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00914	0.00929	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00895	0.0091	CcSEcCtD
Hyoscyamine—Stinging—Fluorouracil—head and neck cancer	0.00894	0.00908	CcSEcCtD
Hyoscyamine—Speech disorder—Fluorouracil—head and neck cancer	0.00842	0.00856	CcSEcCtD
Hyoscyamine—Disorientation—Hydroxyurea—head and neck cancer	0.00816	0.0083	CcSEcCtD
Hyoscyamine—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.00798	0.00811	CcSEcCtD
Hyoscyamine—Leukocytosis—Fluorouracil—head and neck cancer	0.00771	0.00783	CcSEcCtD
Hyoscyamine—Dysarthria—Fluorouracil—head and neck cancer	0.00766	0.00778	CcSEcCtD
Hyoscyamine—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00759	0.00772	CcSEcCtD
Hyoscyamine—Heartburn—Docetaxel—head and neck cancer	0.00759	0.00772	CcSEcCtD
Hyoscyamine—Dermatitis contact—Fluorouracil—head and neck cancer	0.00716	0.00727	CcSEcCtD
Hyoscyamine—Rash erythematous—Docetaxel—head and neck cancer	0.00682	0.00694	CcSEcCtD
Hyoscyamine—Photophobia—Fluorouracil—head and neck cancer	0.0068	0.00691	CcSEcCtD
Hyoscyamine—Angina pectoris—Vinblastine—head and neck cancer	0.00674	0.00685	CcSEcCtD
Hyoscyamine—Coma—Fluorouracil—head and neck cancer	0.00662	0.00672	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00658	0.00669	CcSEcCtD
Hyoscyamine—Ageusia—Docetaxel—head and neck cancer	0.00645	0.00656	CcSEcCtD
Hyoscyamine—Depression—Vinblastine—head and neck cancer	0.00615	0.00625	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00608	0.00618	CcSEcCtD
Hyoscyamine—Myocardial infarction—Vinblastine—head and neck cancer	0.00605	0.00615	CcSEcCtD
Hyoscyamine—Swelling—Fluorouracil—head and neck cancer	0.00596	0.00606	CcSEcCtD
Hyoscyamine—Dysuria—Hydroxyurea—head and neck cancer	0.0059	0.006	CcSEcCtD
Hyoscyamine—Disorientation—Fluorouracil—head and neck cancer	0.00588	0.00597	CcSEcCtD
Hyoscyamine—Drowsiness—Hydroxyurea—head and neck cancer	0.00563	0.00572	CcSEcCtD
Hyoscyamine—Amnesia—Fluorouracil—head and neck cancer	0.00559	0.00569	CcSEcCtD
Hyoscyamine—Lethargy—Fluorouracil—head and neck cancer	0.00536	0.00545	CcSEcCtD
Hyoscyamine—Respiratory failure—Docetaxel—head and neck cancer	0.00532	0.00541	CcSEcCtD
Hyoscyamine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00526	0.00534	CcSEcCtD
Hyoscyamine—Blood pressure increased—Docetaxel—head and neck cancer	0.00523	0.00531	CcSEcCtD
Hyoscyamine—Injection site reaction—Docetaxel—head and neck cancer	0.0052	0.00528	CcSEcCtD
Hyoscyamine—Hallucination—Hydroxyurea—head and neck cancer	0.00503	0.00511	CcSEcCtD
Hyoscyamine—Irritability—Fluorouracil—head and neck cancer	0.00502	0.0051	CcSEcCtD
Hyoscyamine—Cardiac arrest—Fluorouracil—head and neck cancer	0.005	0.00508	CcSEcCtD
Hyoscyamine—Skin exfoliation—Docetaxel—head and neck cancer	0.00499	0.00507	CcSEcCtD
Hyoscyamine—Ataxia—Fluorouracil—head and neck cancer	0.00494	0.00502	CcSEcCtD
Hyoscyamine—Dry skin—Fluorouracil—head and neck cancer	0.00482	0.0049	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Docetaxel—head and neck cancer	0.00465	0.00473	CcSEcCtD
Hyoscyamine—Dysphagia—Fluorouracil—head and neck cancer	0.00454	0.00462	CcSEcCtD
Hyoscyamine—Angina pectoris—Fluorouracil—head and neck cancer	0.00443	0.0045	CcSEcCtD
Hyoscyamine—Erythema—Hydroxyurea—head and neck cancer	0.0044	0.00447	CcSEcCtD
Hyoscyamine—Vertigo—Vinblastine—head and neck cancer	0.00433	0.0044	CcSEcCtD
Hyoscyamine—Swelling—Docetaxel—head and neck cancer	0.0043	0.00437	CcSEcCtD
Hyoscyamine—Convulsion—Vinblastine—head and neck cancer	0.00418	0.00425	CcSEcCtD
Hyoscyamine—Atrial fibrillation—Docetaxel—head and neck cancer	0.004	0.00407	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00399	0.00406	CcSEcCtD
Hyoscyamine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00397	0.00404	CcSEcCtD
Hyoscyamine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00394	0.004	CcSEcCtD
Hyoscyamine—Lethargy—Docetaxel—head and neck cancer	0.00387	0.00393	CcSEcCtD
Hyoscyamine—Convulsion—Hydroxyurea—head and neck cancer	0.00381	0.00387	CcSEcCtD
Hyoscyamine—Hyponatraemia—Docetaxel—head and neck cancer	0.00381	0.00387	CcSEcCtD
Hyoscyamine—Oedema—Hydroxyurea—head and neck cancer	0.00359	0.00365	CcSEcCtD
Hyoscyamine—Ataxia—Docetaxel—head and neck cancer	0.00357	0.00363	CcSEcCtD
Hyoscyamine—Dehydration—Docetaxel—head and neck cancer	0.00353	0.00359	CcSEcCtD
Hyoscyamine—Dry skin—Docetaxel—head and neck cancer	0.00348	0.00353	CcSEcCtD
Hyoscyamine—Constipation—Vinblastine—head and neck cancer	0.00337	0.00342	CcSEcCtD
Hyoscyamine—Pain—Vinblastine—head and neck cancer	0.00337	0.00342	CcSEcCtD
Hyoscyamine—Dysphagia—Docetaxel—head and neck cancer	0.00328	0.00333	CcSEcCtD
Hyoscyamine—Arrhythmia—Fluorouracil—head and neck cancer	0.00325	0.0033	CcSEcCtD
Hyoscyamine—Feeling abnormal—Vinblastine—head and neck cancer	0.00324	0.0033	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00322	0.00327	CcSEcCtD
Hyoscyamine—Dyspnoea—Hydroxyurea—head and neck cancer	0.0032	0.00325	CcSEcCtD
Hyoscyamine—Angina pectoris—Docetaxel—head and neck cancer	0.00319	0.00325	CcSEcCtD
Hyoscyamine—Somnolence—Hydroxyurea—head and neck cancer	0.00319	0.00324	CcSEcCtD
Hyoscyamine—Erythema—Fluorouracil—head and neck cancer	0.00317	0.00322	CcSEcCtD
Hyoscyamine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00316	0.00321	CcSEcCtD
Hyoscyamine—Abdominal pain—Vinblastine—head and neck cancer	0.00311	0.00316	CcSEcCtD
Hyoscyamine—Fatigue—Hydroxyurea—head and neck cancer	0.00309	0.00314	CcSEcCtD
Hyoscyamine—Pain—Hydroxyurea—head and neck cancer	0.00307	0.00312	CcSEcCtD
Hyoscyamine—Constipation—Hydroxyurea—head and neck cancer	0.00307	0.00312	CcSEcCtD
Hyoscyamine—Vision blurred—Fluorouracil—head and neck cancer	0.00298	0.00303	CcSEcCtD
Hyoscyamine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00296	0.00301	CcSEcCtD
Hyoscyamine—Hypersensitivity—Vinblastine—head and neck cancer	0.0029	0.00295	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00288	0.00293	CcSEcCtD
Hyoscyamine—Myocardial infarction—Docetaxel—head and neck cancer	0.00287	0.00291	CcSEcCtD
Hyoscyamine—Conjunctivitis—Docetaxel—head and neck cancer	0.00284	0.00289	CcSEcCtD
Hyoscyamine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00284	0.00288	CcSEcCtD
Hyoscyamine—Asthenia—Vinblastine—head and neck cancer	0.00282	0.00287	CcSEcCtD
Hyoscyamine—Convulsion—Fluorouracil—head and neck cancer	0.00274	0.00279	CcSEcCtD
Hyoscyamine—Chest pain—Fluorouracil—head and neck cancer	0.00269	0.00274	CcSEcCtD
Hyoscyamine—Diarrhoea—Vinblastine—head and neck cancer	0.00269	0.00274	CcSEcCtD
Hyoscyamine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00264	0.00269	CcSEcCtD
Hyoscyamine—Confusional state—Fluorouracil—head and neck cancer	0.0026	0.00265	CcSEcCtD
Hyoscyamine—Dizziness—Vinblastine—head and neck cancer	0.0026	0.00264	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00258	0.00263	CcSEcCtD
Hyoscyamine—Oedema—Fluorouracil—head and neck cancer	0.00258	0.00263	CcSEcCtD
Hyoscyamine—Asthenia—Hydroxyurea—head and neck cancer	0.00258	0.00262	CcSEcCtD
Hyoscyamine—Tachycardia—Fluorouracil—head and neck cancer	0.00252	0.00256	CcSEcCtD
Hyoscyamine—Vomiting—Vinblastine—head and neck cancer	0.0025	0.00254	CcSEcCtD
Hyoscyamine—Headache—Vinblastine—head and neck cancer	0.00247	0.00251	CcSEcCtD
Hyoscyamine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00246	0.0025	CcSEcCtD
Hyoscyamine—Flushing—Docetaxel—head and neck cancer	0.00244	0.00248	CcSEcCtD
Hyoscyamine—Hypotension—Fluorouracil—head and neck cancer	0.00241	0.00245	CcSEcCtD
Hyoscyamine—Dizziness—Hydroxyurea—head and neck cancer	0.00237	0.00241	CcSEcCtD
Hyoscyamine—Arrhythmia—Docetaxel—head and neck cancer	0.00234	0.00238	CcSEcCtD
Hyoscyamine—Nausea—Vinblastine—head and neck cancer	0.00234	0.00238	CcSEcCtD
Hyoscyamine—Insomnia—Fluorouracil—head and neck cancer	0.00234	0.00237	CcSEcCtD
Hyoscyamine—Dyspnoea—Fluorouracil—head and neck cancer	0.0023	0.00234	CcSEcCtD
Hyoscyamine—Mental disorder—Docetaxel—head and neck cancer	0.0023	0.00234	CcSEcCtD
Hyoscyamine—Somnolence—Fluorouracil—head and neck cancer	0.0023	0.00233	CcSEcCtD
Hyoscyamine—Erythema—Docetaxel—head and neck cancer	0.00228	0.00232	CcSEcCtD
Hyoscyamine—Vomiting—Hydroxyurea—head and neck cancer	0.00228	0.00232	CcSEcCtD
Hyoscyamine—Dyspepsia—Fluorouracil—head and neck cancer	0.00227	0.00231	CcSEcCtD
Hyoscyamine—Rash—Hydroxyurea—head and neck cancer	0.00226	0.0023	CcSEcCtD
Hyoscyamine—Dermatitis—Hydroxyurea—head and neck cancer	0.00226	0.0023	CcSEcCtD
Hyoscyamine—Headache—Hydroxyurea—head and neck cancer	0.00225	0.00229	CcSEcCtD
Hyoscyamine—Dysgeusia—Docetaxel—head and neck cancer	0.00224	0.00227	CcSEcCtD
Hyoscyamine—Pain—Fluorouracil—head and neck cancer	0.00221	0.00225	CcSEcCtD
Hyoscyamine—Nausea—Hydroxyurea—head and neck cancer	0.00213	0.00217	CcSEcCtD
Hyoscyamine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00213	0.00216	CcSEcCtD
Hyoscyamine—Urticaria—Fluorouracil—head and neck cancer	0.00205	0.00209	CcSEcCtD
Hyoscyamine—Syncope—Docetaxel—head and neck cancer	0.00205	0.00208	CcSEcCtD
Hyoscyamine—Body temperature increased—Fluorouracil—head and neck cancer	0.00204	0.00208	CcSEcCtD
Hyoscyamine—Palpitations—Docetaxel—head and neck cancer	0.00202	0.00205	CcSEcCtD
Hyoscyamine—Loss of consciousness—Docetaxel—head and neck cancer	0.00201	0.00204	CcSEcCtD
Hyoscyamine—Convulsion—Docetaxel—head and neck cancer	0.00198	0.00201	CcSEcCtD
Hyoscyamine—Chest pain—Docetaxel—head and neck cancer	0.00195	0.00198	CcSEcCtD
Hyoscyamine—Hypersensitivity—Fluorouracil—head and neck cancer	0.0019	0.00193	CcSEcCtD
Hyoscyamine—Dry mouth—Docetaxel—head and neck cancer	0.0019	0.00193	CcSEcCtD
Hyoscyamine—Confusional state—Docetaxel—head and neck cancer	0.00188	0.00191	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00186	0.0019	CcSEcCtD
Hyoscyamine—Oedema—Docetaxel—head and neck cancer	0.00186	0.0019	CcSEcCtD
Hyoscyamine—Shock—Docetaxel—head and neck cancer	0.00183	0.00186	CcSEcCtD
Hyoscyamine—Pruritus—Fluorouracil—head and neck cancer	0.00183	0.00186	CcSEcCtD
Hyoscyamine—Tachycardia—Docetaxel—head and neck cancer	0.00182	0.00185	CcSEcCtD
Hyoscyamine—Diarrhoea—Fluorouracil—head and neck cancer	0.00177	0.0018	CcSEcCtD
Hyoscyamine—Hypotension—Docetaxel—head and neck cancer	0.00174	0.00177	CcSEcCtD
Hyoscyamine—Dizziness—Fluorouracil—head and neck cancer	0.00171	0.00174	CcSEcCtD
Hyoscyamine—Insomnia—Docetaxel—head and neck cancer	0.00169	0.00171	CcSEcCtD
Hyoscyamine—Dyspnoea—Docetaxel—head and neck cancer	0.00166	0.00169	CcSEcCtD
Hyoscyamine—Somnolence—Docetaxel—head and neck cancer	0.00166	0.00168	CcSEcCtD
Hyoscyamine—Vomiting—Fluorouracil—head and neck cancer	0.00164	0.00167	CcSEcCtD
Hyoscyamine—Dyspepsia—Docetaxel—head and neck cancer	0.00164	0.00167	CcSEcCtD
Hyoscyamine—Rash—Fluorouracil—head and neck cancer	0.00163	0.00166	CcSEcCtD
Hyoscyamine—Dermatitis—Fluorouracil—head and neck cancer	0.00163	0.00165	CcSEcCtD
Hyoscyamine—Headache—Fluorouracil—head and neck cancer	0.00162	0.00164	CcSEcCtD
Hyoscyamine—Fatigue—Docetaxel—head and neck cancer	0.00161	0.00163	CcSEcCtD
Hyoscyamine—Pain—Docetaxel—head and neck cancer	0.00159	0.00162	CcSEcCtD
Hyoscyamine—Constipation—Docetaxel—head and neck cancer	0.00159	0.00162	CcSEcCtD
Hyoscyamine—Feeling abnormal—Docetaxel—head and neck cancer	0.00154	0.00156	CcSEcCtD
Hyoscyamine—Nausea—Fluorouracil—head and neck cancer	0.00153	0.00156	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00152	0.00155	CcSEcCtD
Hyoscyamine—Body temperature increased—Docetaxel—head and neck cancer	0.00147	0.0015	CcSEcCtD
Hyoscyamine—Abdominal pain—Docetaxel—head and neck cancer	0.00147	0.0015	CcSEcCtD
Hyoscyamine—Hypersensitivity—Docetaxel—head and neck cancer	0.00137	0.0014	CcSEcCtD
Hyoscyamine—Asthenia—Docetaxel—head and neck cancer	0.00134	0.00136	CcSEcCtD
Hyoscyamine—Pruritus—Docetaxel—head and neck cancer	0.00132	0.00134	CcSEcCtD
Hyoscyamine—Diarrhoea—Docetaxel—head and neck cancer	0.00128	0.0013	CcSEcCtD
Hyoscyamine—Dizziness—Docetaxel—head and neck cancer	0.00123	0.00125	CcSEcCtD
Hyoscyamine—Vomiting—Docetaxel—head and neck cancer	0.00119	0.0012	CcSEcCtD
Hyoscyamine—Rash—Docetaxel—head and neck cancer	0.00118	0.00119	CcSEcCtD
Hyoscyamine—Dermatitis—Docetaxel—head and neck cancer	0.00117	0.00119	CcSEcCtD
Hyoscyamine—Headache—Docetaxel—head and neck cancer	0.00117	0.00119	CcSEcCtD
Hyoscyamine—Nausea—Docetaxel—head and neck cancer	0.00111	0.00113	CcSEcCtD
